Skip to content

Andromeda integrates with Injective to drive DeFi adoption

Andromeda integrates with Injective to drive DeFi adoption

Andromeda, a platform offering a variety of on-chain and multi-chain products, has announced an integration with the finance blockchain Injective, as per the latest updates shared with Finbold on June 27.

The integration is set to accelerate the adoption of decentralized finance (DeFi) and will merge each of the partners’ respective technologies to unlock new economic opportunities.

The Andromeda-Injective partnership

Together, the two partners will work on enhancing the capabilities of both Andromeda, recognized as the first Web3 Operating System, and Injective, the fastest blockchain developed for financial applications. 

The partners will explore new avenues for cross-chain tokens, streamlined asset management, and feature-rich Web3 applications.

One of the primary goals is to implement a solution for tokenized asset management within a unified trading platform. 

This will enable users to fractionalize digital assets, allowing them to be tokenized and traded, increasing the potential for asset appreciation and yield on tokenized assets.

Mant Hawkins, Core Contributor, summarized the main goal of the initiative, stating:

“We believe that by executing our L1 distribution model, we’ll be integrating Andromeda’s on-chain Operating System with Injective’s scalable Layer1 protocol and will unify networks, enabling users to access a diverse array of decentralized applications and DeFi functionalities within a singular platform. In doing so, it will enhance multi-chain/ecosystem composability and enable DeFi innovation to compound.” 

Towards a new wave of DeFi application

The integration is set to benefit both parties by enabling a new wave of DeFi applications that leverage the unique features of each ecosystem. 

Both developers and users will have access to a unified platform that supports innovative financial products, encourages collaboration, and promotes broader adoption.

The combined strengths of Andromeda’s Operating System (aOS) and Injective will facilitate the creation of scalable solutions catering to the evolving needs of the DeFi space.

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in 70+ cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. eToro USA LLC does not offer CFDs, only real Crypto assets available. Don’t invest unless you’re prepared to lose all the money you invest.

Read Next:

Weekly Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Disclaimer: The information on this website is for general informational and educational purposes only and does not constitute financial, legal, tax, or investment advice. This site does not make any financial promotions, and all content is strictly informational. By using this site, you agree to our full disclaimer and terms of use. For more information, please read our complete Global Disclaimer.